Process Validation

(PPQ – Continued Process Verification – Lifecycle Approach)

Process Validation ensures that pharmaceutical manufacturing processes consistently produce products meeting predetermined quality attributes. PrimeGMP provides end-to-end process validation services based on FDA, EU, WHO, and ICH-aligned lifecycle principles, covering Stage 1 (Process Design), Stage 2 (Process Qualification), and Stage 3 (Continued Process Verification – CPV).

Objectives of Process Validation

  • Demonstrate process consistency and reproducibility
  • Confirm product CQAs & CPPs remain under control
  • Establish validated operating ranges and worst-case parameters
  • Verify equipment, utilities, and controls perform consistently
  • Ensure regulatory readiness and lifecycle alignment
  • Strengthen the organization’s quality and compliance framework

Process Validation Lifecycle

  1. Stage 1 – Process Design
  • Review of product & formulation development data
  • Identification of CPPs, CQAs & CMAs
  • Risk assessment (FMEA, Fishbone, Ishikawa)
  • Development of control strategy
  • Process scale-up and trial evaluation
  • Identification of worst-case parameters
  1. Stage 2 – Process Qualification (PPQ)

Includes Equipment / Facility / Utility readiness

  • PPQ Protocol preparation
  • Verification of equipment qualification (DQ–IQ–OQ–PQ)
  • Review of raw material controls
  • Verification of operator training & readiness
  • Controlled batch manufacturing runs
  • Testing of in-process controls, yield, uniformity, and consistency
  • Demonstration of batch-to-batch reproducibility
  • Statistical evaluation of PPQ batches
  • Trending of critical parameters & test results
  1. Stage 3 – Continued Process Verification (CPV)
  • Routine monitoring of process data
  • Trending of CPPs, CQAs, yields & quality parameters
  • Verification of statistical control (Cp, Cpk, control charts)
  • Annual product quality review data integration
  • Review of deviations, OOS, OOT & CAPA
  • Lifecycle assessment for periodic revalidation

Support for Various Dosage Forms

  • Oral solid dosage (tablets, capsules)
  • Sterile injections (SVP, LVP, lyophilized)
  • Dry powder injections
  • Ointments & creams
  • Liquid orals & suspensions
  • API manufacturing
  • Biotech & fermentation processes

Documentation Provided

  • Process Validation Master Plan (PVMP)
  • Risk assessments
  • PPQ Protocols
  • Executed PPQ batch documentation
  • Statistical analysis reports
  • CPV plans & ongoing monitoring templates
  • Final Process Validation Reports
  • Revalidation strategy & recommendations

Regulatory Standards Followed

  • USFDA Process Validation Guidance – 2011
  • EU GMP Annex 15 (Qualification & Validation)
  • ICH Q8 (Pharmaceutical Development)
  • ICH Q9 (Quality Risk Management)
  • ICH Q10 (Pharmaceutical Quality System)
  • WHO TRS 1019
  • PIC/S Guidance (PI 006)

Why Choose PrimeGMP for Process Validation?

  • Strong experience in PPQ execution across multiple dosage forms
  • Expertise in lifecycle-based validation aligned with global regulators
  • Robust statistical evaluation & trending capability
  • End-to-end integration with equipment, utility, and cleaning validations
  • Clear, concise, audit-ready documentation
  • Practical problem-solving during PPQ & CPV failures
You have been successfully Subscribed! Ops! Something went wrong, please try again.

Contact

info@primegmp.com

+91 6280308573

523A, Diamond Avenue, Majitha Road, Amritsar, Punjab, India

© 2025 Prime GMP |  Design by Lead Fusion